1 post published by crowtherconsulting during October 2025| Making rights make sense
Image from the Grayson Perry exhibition at the Wallace Collection, October 2025 A short post, as I struggle not just for time at the moment but to find the mental resources to commit ideas to writi…| Making rights make sense
After a really hectic week it was wonderful to spend last weekend getting away with my two oldest friends for a weekend’s camping, walking, drinking and eating in the countryside around Strou…| Making rights make sense
‘We want to focus on what people can do, not what they can’t’ has been a mantra of politicians when it comes to reforming disability related social security benefits for the past …| Making rights make sense
You’re in your early 80s living alone, having lost your husband, who’d been living with dementia, during the pandemic. You did everything together for so long, marrying in your early 20…| Making rights make sense
Various recent conversations, experiences and developments, positive and negative have prompted me to write this post about #SocialCareFuture, the movement I helped to kickstart and which I still c…| Making rights make sense
I’ve just listened to Rachel Reeves trying to justify planned cuts to disability benefits on the Today programme by relying on the ‘disabled people want to work and the system writes th…| Making rights make sense
“Without reform more people will be locked out of jobs, despite many wanting to work.” – UK Government commenting on an article about increased spending on Personal Independence Payment…| Making rights make sense
I’m a hopeless, slow book reader, rarely getting through a novel unless pinned to a sun bed for several days. So the fact I received my copy of Maff Potts’ ‘Friends and Purpose…| Making rights make sense
“The social care sector is on its last legs. Without urgent action, there will be nothing left to reform.” Dr Jane Townson, CEO, Homecare Association We begin 2025 much as we have the past decade w…| Making rights make sense
Last week, NICE echoed its earlier position on the Alzheimer’s drug lecenamab and advised that the benefits of donanemab did not, based on current evidence outweigh the costs of making it available on the NHS concluding that ‘The costs of providing donanemab, including regular infusions and intensive monitoring for serious side effects, balanced against the […]| Making rights make sense